Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy.

Xiao, Wei; Ibrahim, Mohammed L; Redd, Priscilla S; Klement, John D; Lu, Chunwan; Yang, Dafeng; Savage, Natasha M; Liu, Kebin

Xiao, Wei; Ibrahim, Mohammed L; Redd, Priscilla S; Klement, John D; Lu, Chunwan; Yang, Dafeng; Savage, Natasha M; Liu, Kebin.

Afiliação

Xiao W; Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta, Georgia.
Ibrahim ML; Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta, Georgia.
Redd PS; Georgia Cancer Center, Medical College of Georgia, Augusta, Georgia.
Klement JD; Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta, Georgia.
Lu C; Georgia Cancer Center, Medical College of Georgia, Augusta, Georgia.
Yang D; Charlie Norwood VA Medical Center, Augusta, Georgia.
Savage NM; Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta, Georgia.
Liu K; Georgia Cancer Center, Medical College of Georgia, Augusta, Georgia.

Mol Cancer Res ; 17(2): 420-430, 2019 02.

Article em En | MEDLINE | ID: mdl-30429213

Assuntos

Neoplasias do Colo/genética; Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos; Imunoterapia/métodos; Receptor fas/metabolismo; Animais; Linhagem Celular Tumoral; Modelos Animais de Doenças; Humanos; Camundongos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo / Resistencia a Medicamentos Antineoplásicos / Receptor fas / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google